Adam Hartigan, based in United States, is currently a Vice President, Program Leader, Hematology at Beam Therapeutics, bringing experience from previous roles at FogPharma, Beam Therapeutics, Fogpharma and Magenta Therapeutics. Adam Hartigan holds a University of Michigan, Ann Arbor. With a robust skill set that includes Mouse Models, Cell Biology, Immunology, Molecular Biology, Stem Cells and more, Adam Hartigan contributes valuable insights to the industry. Adam Hartigan has 3 emails on RocketReach.